Abstract
The serologic markers of the therapeutic response of chronic necrotizing pulmonary aspergillosis (CNPA) are rarely reported. Here, we describe the changes in galactomannan (GM) antigenemia in a patient receiving oral voriconazole for CNPA, in whom a resolution of GM antigenemia to a normal level was associated with clinical improvements. The serum GM index can be an adjunctive tool for the diagnosis and monitoring of the therapeutic response of CNPA.
Original language | English |
---|---|
Pages (from-to) | 528-530 |
Number of pages | 3 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 70 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2011 Aug |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases